Rights and permissions
About this article
Cite this article
Radiolabelled octreotate particularly useful in patients with regression. Pharmacoecon. Outcomes News 459, 13 (2004). https://doi.org/10.2165/00151234-200404590-00036
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404590-00036